Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Medicine, Internal medicine, Cancer, Microsatellite instability, Single-nucleotide polymorphism, and Chemotherapy.
Dissecting the genetic heterogeneity of gastric cancer
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients
Low microsatellite instability: A distinct instability type in gastric cancer?
Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations
Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer”
eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma
Sexual Difference Matters: Females with High Microsatellite Instability Show Increased Survival after Neoadjuvant Chemotherapy in Gastric Cancer
Diverse ‘just-right’ levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs
Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric Cancer
Germline variation in the insulin-like growth factor pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma
Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein–Barr virus infection and high‐ and low‐microsatellite instability
No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study
Evidence for <i><scp>PTGER</scp>4</i>,<i><scp>PSCA</scp>,</i> and <i><scp>MBOAT</scp>7</i> as risk genes for gastric cancer on the genome and transcriptome level
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
The Barrett‐associated variants at <i><scp>GDF</scp>7</i> and <i><scp>TBX</scp>5</i> also increase esophageal adenocarcinoma risk
Association of angiogenic factors with prognosis in esophageal cancer
Supportive evidence for <i><scp>FOXP</scp>1</i>,<i><scp>BARX</scp>1</i>, and <i><scp>FOXF</scp>1</i> as genetic risk loci for the development of esophageal adenocarcinoma
Serum micro<scp>RNA</scp> profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction